Syros Pharmaceuticals, Inc.
DelistedCIK 1556263fmd_1YBH35E1ZANDHX1EVVPTA7FGMMManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2014 to Sep 30, 2024, 40 periods
Latest annual · FY2023
Millions- Total revenues
- 10
- Operating income
- (129)
- Net income
- (165)
- Free cash flow
- (110)
Latest quarter · Q3 FY2024
Millions- Operating income
- (26)
- Net income
- (6)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2020 to FY2023
- -13.0%
- Revenue, 5 yearsFY2018 to FY2023
- +37.1%
- Net income, 5 yearsFY2018 to FY2023
- n/m
Syros Pharmaceuticals, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2023 | FY2022 | Change | Source |
|---|---|---|---|---|
| Revenue | $9.9 million | $14.9 million | -33.2% | 10-K 2024-03-27 · proof |
| Operating income | -$129 million | -$135.9 million | 10-K 2024-03-27 · proof | |
| Net income | -$164.6 million | -$94.7 million | 10-K 2024-03-27 · proof | |
| Cash from operating activities | -$109.7 million | -$123.1 million | 10-K 2024-03-27 · proof | |
| Free cash flow | -$110 million | -$124.3 million | 10-K 2024-03-27 · proof | |
| Total assets | $168.2 million | $244.5 million | -31.2% | 10-K 2024-03-27 · proof |
| Total liabilities | $151.5 million | $116.8 million | +29.8% | 10-K 2024-03-27 · proof |
| Cash and cash equivalents | $139.5 million | $167.5 million | -16.7% | 10-K 2024-03-27 · proof |
| Total debt | $41.2 million | 10-K 2024-03-27 · proof |
- What was Syros Pharmaceuticals, Inc.'s revenue in fiscal 2023?
- Syros Pharmaceuticals, Inc. reported revenue of $9.9 million for fiscal 2023 (the year ended Dec 31, 2023), against $14.9 million the year before (-33.2%). Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What was Syros Pharmaceuticals, Inc.'s operating income in fiscal 2023?
- Syros Pharmaceuticals, Inc. reported operating income of -$129 million for fiscal 2023 (the year ended Dec 31, 2023), against -$135.9 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What was Syros Pharmaceuticals, Inc.'s net income in fiscal 2023?
- Syros Pharmaceuticals, Inc. reported net income of -$164.6 million for fiscal 2023 (the year ended Dec 31, 2023), against -$94.7 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What was Syros Pharmaceuticals, Inc.'s cash from operating activities in fiscal 2023?
- Syros Pharmaceuticals, Inc. reported cash from operating activities of -$109.7 million for fiscal 2023 (the year ended Dec 31, 2023), against -$123.1 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What was Syros Pharmaceuticals, Inc.'s free cash flow in fiscal 2023?
- Syros Pharmaceuticals, Inc. reported free cash flow of -$110 million for fiscal 2023 (the year ended Dec 31, 2023), against -$124.3 million the year before. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What are Syros Pharmaceuticals, Inc.'s total assets?
- As of Dec 31, 2023, Syros Pharmaceuticals, Inc. reported total assets of $168.2 million, against $244.5 million a year earlier (-31.2%). Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What are Syros Pharmaceuticals, Inc.'s total liabilities?
- As of Dec 31, 2023, Syros Pharmaceuticals, Inc. reported total liabilities of $151.5 million, against $116.8 million a year earlier (+29.8%). Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What are Syros Pharmaceuticals, Inc.'s cash and cash equivalents?
- As of Dec 31, 2023, Syros Pharmaceuticals, Inc. reported cash and cash equivalents of $139.5 million, against $167.5 million a year earlier (-16.7%). Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
- What is Syros Pharmaceuticals, Inc.'s total debt?
- As of Dec 31, 2023, Syros Pharmaceuticals, Inc. reported total debt of $41.2 million. Source: the 10-K filed with the SEC on Mar 27, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1556263&period_type=annual&limit=5"Information only, not investment advice.